David M Jackman - Dana-Farber Cancer Institute

基本信息

浏览量：106

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 151 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of Pathways Navigation Status on Approval Rates and Outcomes of Oral Lung Cancer Treatments

Belinda Desravines, Debbie Castelot, Jason Poquette, Trang N. Nguyen,Leila Rostamnjad, Omar Waid,David Michael Jackman

JCO Oncology Practice（2024）

引用0浏览0引用

Using Oncology Treatment Pathway Data to Evaluate Serious Illness Communication, Care Utilization, and End-of-Life Care for Patients with Cancer

Cody E Cotner,Angela C Tramontano, Alex Post, Brian Finn, Saima Awan, Nathaniel Gwynne,Sishemo Mwesigwa,Charlotta Lindvall,James A Tulsky,Joseph O Jacobson,David M Jackman,Alexi A Wright,Christopher R Manz

JCO oncology practice（2024）

引用0浏览0WOS引用

Novel Use of Clinical Pathways to Improve Clinical Trial Accrual

Joanna Addonizio, Alex Post,Matthew Rice, Carly Powell,Sunyi Zhang, Trang N. Nguyen, Hao-Yu Chang, Shruti Gupta,Erica Fox,David Michael Jackman

JCO Oncology Practice（2024）

引用0浏览0引用

Phase II Study of Defactinib (VS6063) in Patients with Tumors with NF2 Loss: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U

Marjorie G. Zauderer,Opeyemi Jegede,David M. Jackman,James A. Zwiebel,Robert J. Gray,Victoria Wang,Lisa M. Mcshane,Larry V. Rubinstein,David R. Patton,P. Mickey Williams,Stanley R. Hamilton,Naoko Takebe, Raymond Huang, Jose A. Carrillo, Andrew J. Brenner,James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay N. Harris,Peter J. O'Dwyer,Alice P. Chen,Keith T. Flaherty

JCO PRECISION ONCOLOGY (2024)

引用0浏览0WOS引用

Noninvasive Detection of Response and Resistance in EGFR-mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

Geoffrey R. Oxnard,Cloud P. Paweletz,Yanan Kuang,Stacy L. Mach,Allison O'Connell,Melissa M. Messineo,Jason J. Luke,Mohit Butaney,Paul Kirschmeier,David M. Jackman,Pasi A. Janne

pubmed（2023）

引用797浏览0WOS引用

797

Use of Clinical Pathways to Identify Patients with Cancer Who May Benefit from Serious Illness Conversations

Cody E. Cotner,Angela Tramontano,David Michael Jackman,James A. Tulsky,Joseph Jacobson,Matthew Rice, Alex Post, Brian Finn,Sishemo Mwesigwa,Charlotta Lindvall,Alexi A. Wright,Christopher Manz

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用0浏览0引用

Supp. Table 3 from Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Antonio Calles,Lynette M. Sholl,Scott J. Rodig,Ashley K. Pelton,Jason L. Hornick,Mohit Butaney,Christine Lydon,Suzanne E. Dahlberg,Geoffrey R. Oxnard,David M. Jackman,Pasi A. Jänne

crossref（2023）

引用0浏览0引用

Supp. Table 2 from Immunohistochemical Loss of LKB1 is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma

Antonio Calles,Lynette M. Sholl,Scott J. Rodig,Ashley K. Pelton,Jason L. Hornick,Mohit Butaney,Christine Lydon,Suzanne E. Dahlberg,Geoffrey R. Oxnard,David M. Jackman,Pasi A. Jänne

openalex（2023）

引用0浏览0引用

Supp. Table 4 from Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Antonio Calles,Lynette M. Sholl,Scott J. Rodig,Ashley K. Pelton,Jason L. Hornick,Mohit Butaney,Christine Lydon,Suzanne E. Dahlberg,Geoffrey R. Oxnard,David M. Jackman,Pasi A. Jänne

crossref（2023）

引用0浏览0引用

Supplemental Figure 2 from Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma

Antonio Calles,Lynette M. Sholl,Scott J. Rodig,Ashley K. Pelton,Jason L. Hornick,Mohit Butaney,Christine Lydon,Suzanne E. Dahlberg,Geoffrey R. Oxnard,David M. Jackman,Pasi A. Jänne

crossref（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn